Lidings’ IP team has successfully secured recognition of the Doppelherz brand as a well-known trademark specifically for dietary supplements, setting a valuable precedent. The interests of the client, the German pharmaceutical company Queisser Pharma, which owns the brand, were represented by Boris Malakhov, Partner, and Vladislav Ryabov, Senior Associate.

Lidings' sanctions compliance and corporate & M&A practice lawyers managed the conversion of depositary receipts (ADRs) into stocks of a Russian issuer in support of private clients from Europe and the United States.

Lidings is pleased to announce the joining of an expert in legal matters in transportation and logistics industry - Sergey Vasilyev.

Lidings Intellectual Property team has helped a major Russian manufacturer of pharmaceuticals, Pharmnovations, to achieve the annulment of the marketing authorization for a generic drug of a competitor company.

Lidings takes high positions in the new rating of the leading legal advisors in Russia based on the analytical research held annually by the “Kommersant” newspaper. In 2023 the firm is ranked among the TOP leading legal advisors in Russia. 

On 2 December 2022 the results of the annual Pravo-300 law firms’ ranking were announced at an awarding ceremony at The Carlton Hotel in Moscow. Lidings’ top position among the leading legal advisors in Russia once again reflected by the ranking results.

Restriction Impossible to be Registered: Lidings Team Defends Interests of Major Russian Pharmaceutical Manufacturer in Patent Dispute Over Registration of Generic.

The main metaphor we used in creating new visual depiction of Lidings brand is crystal – transparent and concise, discreet, high status, stylish and expressive.